92 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:19pm
Liabilities and Shareholders’ Equity
Nature of Operations (Note 1)
Commitments (Note 16)
Subsequent events (Note 18)
/s/ “Allen Davidoff”
/s/ “Paul … Consolidated Financial Statements
For the three months ended March 31, 2024 and 2023
(Unaudited - expressed in U.S. Dollars)
Nature of operations
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
commercialization of our product candidates and adversely impact our potential to generate revenue, our business and our results of operations. The nature of clinical … , nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:17pm
in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where … advisory services of any nature or respect, or owe an agency, fiduciary or similar duty to the Company, in connection with such transaction or the process
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:15pm
(Unaudited - expressed in U.S. Dollars)
Nature of operations
XORTX Therapeutics Inc. (the “Company” or “XORTX”) was incorporated under the laws … and estimates that affect the amounts reported in the condensed interim consolidated financial statements and notes. By their nature, these judgments
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:12pm
Liabilities and Shareholders’ Equity
Nature of Operations (Note 1)
Commitments (Note 16)
Subsequent events (Note 18)
/s/ “Allen Davidoff”
/s … Interim Consolidated Financial Statements
For the three months ended March 31, 2024 and 2023
(Unaudited - expressed in U.S. Dollars)
Nature of operations
424B3
7iegtt81ckpe82rlnt
13 Jun 24
Prospectus supplement
4:11pm
424B3
s5n0eui 2dxep
13 Jun 24
Prospectus supplement
4:10pm
424B3
flwsa
13 Jun 24
Prospectus supplement
4:10pm
6-K
EX-99.1
3fkbynug
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-99.2
nsqyakje a6cb8
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-10.1
dt5xde9 9ylm1j
30 Nov 23
XORTX Announces US ATM Offering
4:04pm
424B5
63c 027ydfqe7tvwo
29 Nov 23
Prospectus supplement for primary offering
9:57pm
6-K
EX-99.1
jacw8g53wylo gcyqj8z
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm
6-K
EX-99.2
18xode 7dsp
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm
424B3
bwf0 mwlf
25 Aug 23
Prospectus supplement
6:00am
424B3
vtatea1ox6s0v
25 Aug 23
Prospectus supplement
6:00am
6-K
EX-99.2
o2cri49c
15 Aug 23
Condensed Interim Consolidated Financial Statements
6:00am